Modernizing Medicine Announces Brian Boyd as Chief Revenue Officer

Mr. Boyd will oversee the sales organization while continuing to build on the health IT company’s rapid growth

BOCA RATON, Fla.–(BUSINESS WIRE)–Modernizing Medicine® is proud to announce the appointment of Brian Boyd as its new Chief Revenue Officer (CRO). Mr. Boyd brings over 20 years of leadership experience in the technology and services industries to now oversee Modernizing Medicine’s entire sales organization including sales, sales operations and business development teams.

“Joining Modernizing Medicine at such a pivotal time for the healthcare industry is very exciting, and I’m looking forward to becoming part of such a collaborative and robust team,” Mr. Boyd said about his new role. “Focusing on implementing creative, yet scalable solutions to maximize continued customer success will help our company and customers to continue to thrive in a rapidly changing industry.”

Mr. Boyd joins Modernizing Medicine from SAP Fieldglass, where he was a regional vice president of sales in the Americas at the cloud-based vendor management solution that automates the process of sourcing and managing external talent. During his tenure at SAP Fieldglass, Mr. Boyd built the U.S. sales organization and expanded the business internationally into the Latin American market. He previously was at ManpowerGroup in global solutions and sales.

“Brian brings with him the perfect mix of entrepreneurial drive and proven success scaling up a sales organization from early stage to large enterprise,” said Joe Harpaz, president and COO at Modernizing Medicine. “Brian also has extensive experience developing partnerships and sales channel relationships on a global basis. We welcome him to our team as we work together to transform how healthcare information is created, consumed and utilized to increase practice efficiency and improve patient outcomes.”

Modernizing Medicine’s leadership team is comprised of top professionals with experience in the financial, operational, sales, and medical fields. The company’s flagship product, the electronic health record (EHR) system, EMA®, is used by over 14,000 providers across the U.S. and has received many awards for usability and innovation in specialty-specific healthcare technology.

Mr. Boyd earned an MBA from Marquette University in Milwaukee, Wis., and an undergraduate degree in business administration and computer science from St. Norbert College in De Pere, Wis.

To learn more about Modernizing Medicine and meet the rest of its leadership team, please visit www.modmed.com.

About Modernizing Medicine

Modernizing Medicine® and its affiliated companies empower physicians with suites of mobile, specialty-specific solutions that transform how healthcare information is created, consumed and utilized to increase practice efficiency and improve patient outcomes. Built for value-based healthcare, Modernizing Medicine’s data-driven, touch- and cloud-based products and services are programmed by a team that includes practicing physicians to meet the unique needs of dermatology, gastroenterology, ophthalmology, orthopedics, otolaryngology, pain management, plastic surgery and urology practices, as well as ambulatory surgery centers. For more information, please visit www.modmed.com. Connect with Modernizing Medicine on our Blog, Facebook, LinkedIn and Twitter.

Contacts

Modernizing Medicine

Lesley Weisenbacher

412-726-5122

lesley.weisenbacher@modmed.com

www.modmed.com


Matter Health for Modernizing Medicine

Jessica Wolter

978-518-4536

modmed@matternow.com

www.matternow.com

Staff

Recent Posts

Empatho Holdings Inc. Announces Litigation

Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Empatho Holdings Inc. (the "Company") announces that…

25 mins ago

ZetrOZ Systems Marks Mid-Year with Presentations at Major Athletic and Military Medicine Conferences

Makers of the sam® wearable ultrasound unit present new research on the effectiveness of sustained…

2 hours ago

Veterinarians Putting Children First

Child care in the Veterinary IndustryBEND, OR / ACCESSWIRE / June 18, 2024 / Vet…

2 hours ago

Cosmo’s Oral Diagnostic Drug Lumeblue(R) Receives Approval of New Drug Application in China

Dublin, Ireland--(Newsfile Corp. - June 18, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43)…

4 hours ago

Healing Realty Trust Closes First Tranche of Series A to Expand Clinic-Focused Portfolio for a New Generation of Medicine

Investment to fund acquisitions of three operating healthcare facilities in Texas, Ohio and Connecticut, totaling…

5 hours ago